205 related articles for article (PubMed ID: 8616825)
1. Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies.
Beck J; Gekeler V; Ringger M; Handgretinger R; Niethammer D
Cancer Lett; 1996 Feb; 99(2):197-207. PubMed ID: 8616825
[TBL] [Abstract][Full Text] [Related]
2. Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivative.
Beck JF; Buchholz F; Ulrich WR; Boer R; Sanders KH; Niethammer D; Gekeler V
Cancer Lett; 1998 Jul; 129(2):157-63. PubMed ID: 9719457
[TBL] [Abstract][Full Text] [Related]
3. Differential activity of P-glycoprotein in normal blood lymphocyte subsets.
Ludescher C; Pall G; Irschick EU; Gastl G
Br J Haematol; 1998 Jun; 101(4):722-7. PubMed ID: 9674746
[TBL] [Abstract][Full Text] [Related]
4. A simplified approach to determining P-glycoprotein expression in peripheral blood mononuclear cell subsets.
Ford J; Hoggard PG; Owen A; Khoo SH; Back DJ
J Immunol Methods; 2003 Mar; 274(1-2):129-37. PubMed ID: 12609539
[TBL] [Abstract][Full Text] [Related]
5. Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cells.
Taylor BJ; Olson DP; Ivy SP
Leuk Res; 2001 Dec; 25(12):1127-35. PubMed ID: 11684287
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells].
Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y
Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264
[TBL] [Abstract][Full Text] [Related]
7. Detection of P glycoprotein activity on normal and leukemic CD34+ cells.
Drenou B; Fardel O; Amiot L; Fauchet R
Leuk Res; 1993 Dec; 17(12):1031-5. PubMed ID: 7504150
[TBL] [Abstract][Full Text] [Related]
8. In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
Baines P; Limaye M; Hoy T; Padua RA; Whittaker J; al-Sabah A; Burnett A
Leuk Res; 1994 Sep; 18(9):683-91. PubMed ID: 7934144
[TBL] [Abstract][Full Text] [Related]
9. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities.
Uchida N; Combs J; Chen S; Zanjani E; Hoffman R; Tsukamoto A
Blood; 1996 Aug; 88(4):1297-305. PubMed ID: 8695847
[TBL] [Abstract][Full Text] [Related]
10. HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
Lucia MB; Rutella S; Leone G; Vella S; Cauda R
J Acquir Immune Defic Syndr; 2001 Aug; 27(4):321-30. PubMed ID: 11468419
[TBL] [Abstract][Full Text] [Related]
11. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
12. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.
Drach D; Zhao S; Drach J; Mahadevia R; Gattringer C; Huber H; Andreeff M
Blood; 1992 Dec; 80(11):2729-34. PubMed ID: 1360266
[TBL] [Abstract][Full Text] [Related]
13. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subset analysis by Boolean algebra: a phenotypic approach using a cocktail of 5 antibodies and 3 color immunofluorescence.
Hunter SD; Peters LE; Wotherspoon JS; Crowe SM
Cytometry; 1994 Mar; 15(3):258-66. PubMed ID: 7514523
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein activity is decreased in CD4+ but not CD8+ lung allograft-infiltrating T cells during acute cellular rejection.
Donnenberg VS; Burckart GJ; Zeevi A; Griffith BP; Iacono A; McCurry KR; Wilson JW; Donnenberg AD
Transplantation; 2004 Jun; 77(11):1699-706. PubMed ID: 15201669
[TBL] [Abstract][Full Text] [Related]
16. Detection of lymphocyte subsets using three-color/single-laser flow cytometry and the fluorescent dye peridinin chlorophyll-alpha protein.
Afar B; Merrill J; Clark EA
J Clin Immunol; 1991 Sep; 11(5):254-61. PubMed ID: 1686614
[TBL] [Abstract][Full Text] [Related]
17. Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans.
Aggarwal S; Tsuruo T; Gupta S
J Clin Immunol; 1997 Nov; 17(6):448-54. PubMed ID: 9418184
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients.
Donnenberg VS; Burckart GJ; Griffith BP; Jain AB; Zeevi A; Berg AD
J Clin Pharmacol; 2001 Dec; 41(12):1271-9. PubMed ID: 11762554
[TBL] [Abstract][Full Text] [Related]
19. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.
Chaudhary PM; Mechetner EB; Roninson IB
Blood; 1992 Dec; 80(11):2735-9. PubMed ID: 1360267
[TBL] [Abstract][Full Text] [Related]
20. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.
Hitzl M; Drescher S; van der Kuip H; Schäffeler E; Fischer J; Schwab M; Eichelbaum M; Fromm MF
Pharmacogenetics; 2001 Jun; 11(4):293-8. PubMed ID: 11434506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
